ENTPD1 and systemic lupus erythematosus: Last, CD39 was assessed as a possible biomarker for the activity of SLE illness.<h4>Results</h4>Compared to the SLE low-activity group, the SLE active group's peripheral blood had a larger percentage and quantity of CD4-positive T cells.